Skip to main content
. Author manuscript; available in PMC: 2020 Sep 17.
Published in final edited form as: Aliment Pharmacol Ther. 2018 Aug 22;48(7):696–703. doi: 10.1111/apt.14937

TABLE 1.

Study level characteristics: NASH subjects without cirrhosis compared to other aetiologies of chronic liver disease without cirrhosis

Reference Year published Years enrolled Study design NASH definition Confounders adjusted for ALD definition NASH (%) HCV (%) ALD (%) HBV (%) Other/Not specified (%)a
Ertle et al42 2011 2007–2008 Retrospective cross-sectional Liver histology or cryptogenic liver disease in the presence of metabolic syndrome Diabetes
Obesity
>2 drinks/day or >6 drinks daily on weekends for >5 years 36.4 (n = 59) 21.6 (n = 35) 11.7 (n = 19) 17.9 (n = 29) 12.3 (n = 20)
Reddy et al29 2012 2000–2010 Prospective cohort (median follow-up 50 mo) Liver histology Diabetes
Obesity
2 drinks per day 24.3 (n = 52) 75.7 (n =162)
Tokushige et al9 2013 2006–2009 Prospective cohort (5 year follow-up) Expert clinical opinion Age
Gender
N/A 2.0 (n = 292) Not presented Not presented Not presented 98.0 (n = 14 238)
Schutte et al30 2014 1994–2013 Retrospective cohort (median follow-up not described) Ultrasound with steatosis in the absence of other liver disease Age
Diabetes
Gender
Obesity
>70 g/day of alcohol or history of alcohol abuse in medical record 6.5 (n = 43) 3.2 (n = 21) 15.1 (n =100) 4.3 (n = 29) 71.0 (n = 471)
Rim et al31 2014 2005–2012 Cross-sectional Expert clinical opinion Not stated N /A 7.9 (n = 35) 92.1 (n = 724)
Tateishi et al16 2015 1991–2010 Prospective cohort (up to 20 years follow-up) Expert clinical opinion Age
Diabetes
Gender
Obesity
>80 g/day without another definitive aetiology 11.2 (n = 590) Not presented 27.2 (N = 1423) Not presented 61.5 (n = 3217)
Mittal et al17 2015 2004–2011 Retrospective cohort (up to 6 years follow-up) Liver histology or cryptogenic liver disease in the presence of metabolic syndrome Age
Ethnicity
>3 drinks a day, alcoholism/alcohol abuse in the medical record, enrolment in substance abuse program and/or history of alcoholic hepatitis 8.0 (n = 120) 67.5 (n = 1013) 19.1 (n = 286) 4.6 (n = 69) 0.8 (n = 12)
a

Includes any combination of hepatitis B, hepatitis C (if not captured separately), alcoholic liver disease (if not captured separately) autoimmune, hemochromatosis, primary sclerosing cholangitis, primary biliary cirrhosis, Wilson’s disease, toxic liver disease.